+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gene Amplification Technologies Market by Product Type, Technology Type, End User, Application - Global Forecast to 2030- Product Image
Gene Amplification Technologies Market by Product Type, Technology Type, End User, Application - Global Forecast to 2030- Product Image
Sale

Gene Amplification Technologies Market by Product Type, Technology Type, End User, Application - Global Forecast to 2030

  • PDF Icon

    Report

  • 191 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5887206
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Gene Amplification Technologies Market grew from USD 27.91 billion in 2024 to USD 29.16 billion in 2025. It is expected to continue growing at a CAGR of 4.43%, reaching USD 36.22 billion by 2030.

Introduction to the Next Generation of Amplification Techniques

The gene amplification landscape has undergone rapid evolution, driven by advances in molecular biology and growing demands for precision diagnostics and research. As the bedrock of modern genomic workflows, amplification techniques such as digital PCR, quantitative PCR, isothermal methods, and next-generation assays have become indispensable across sectors from clinical diagnostics to agricultural testing.

With recent breakthroughs in microfluidics and enzyme engineering, researchers and industry leaders are witnessing unprecedented sensitivity and throughput gains. These developments are transforming how laboratories detect trace nucleic acids, monitor gene expression, and identify pathogens. This report opens with an overview of these foundational trends, setting the stage for a deeper exploration of market drivers, challenges, and strategic implications for stakeholders.

Emerging Paradigms Driving Market Evolution

The past two years have witnessed transformative shifts reshaping the gene amplification market. First, the convergence of digital PCR and high-throughput sequencing technologies has enabled absolute quantification with unparalleled precision, empowering laboratories to tackle complex genomic applications with greater confidence. At the same time, isothermal amplification methods such as loop-mediated isothermal amplification and recombinase polymerase amplification have gained favor for point-of-care diagnostics, offering rapid turnaround without thermocyclers.

Concurrently, software platforms for data analysis have evolved from simple threshold-based tools to advanced cloud-enabled suites incorporating artificial intelligence and machine learning algorithms. This evolution is closing the gap between raw data generation and actionable insights, accelerating decision-making in fields from oncology to environmental monitoring. Together, these shifts are driving product innovation, strategic partnerships, and renewed investment in decentralized testing models that promise to democratize access to gene-based assays.

Assessing the Impact of 2025 US Import Tariffs

The introduction of new tariffs by the United States in 2025 has imposed additional costs on imported amplification instruments and reagents, creating headwinds for manufacturers and end users alike. Suppliers have responded by reevaluating their global supply chains, increasing domestic production capabilities, and identifying alternative sourcing strategies to mitigate the impact of duties. Some reagent producers have relocated mix and fill operations closer to end markets to bypass steep import levies, while instrument manufacturers are forging partnerships with local distributors to streamline logistics and reduce landed costs.

Despite these measures, price pressures persist, prompting many buyers to extend existing contracts, consolidate orders, or explore reagent rental programs to optimize budgets. While short-term disruptions have eased as stakeholders adjust, the cumulative effect of tariffs has highlighted the importance of supply chain resilience and cost transparency in procurement decisions. As the market continues to navigate this new trade environment, companies that prioritize local manufacturing and flexible distribution networks will be best positioned to sustain growth and preserve margins.

Holistic View of Market Segmentation

Analysis of product type segmentation reveals that consumables and reagents remain the largest revenue contributor, led by enzymes optimized for high-fidelity amplification, pre-formulated kits tailored to specific targets, and a broad palette of custom reagents that enable niche applications. Instruments follow closely, with digital PCR platforms capturing share through absolute quantification and high multiplexing capacity, while thermal cyclers and qPCR machines continue to attract core laboratory investments. Software and services have emerged as an indispensable complement, offering turnkey analysis pipelines and expert consulting for complex experimental design.

From a technology standpoint, traditional PCR and qPCR systems account for foundational volumes, whereas digital PCR is the fastest expanding segment, driven by demands for ultra-sensitive detection in liquid biopsy and minimal residual disease monitoring. Isothermal amplification modalities such as HDA, LAMP, and RPA are gaining traction where speed and portability are paramount, notably in field-based environmental surveillance and decentralized diagnostic settings.

End user segmentation underscores the diversity of market drivers. Academic institutions and research institutes fuel fundamental discovery and method development, while diagnostic laboratories and hospital networks deploy amplification assays for routine clinical testing. Pharmaceutical companies, spanning both big pharma and biotech, invest heavily in gene amplification for target validation, companion diagnostics development, and cell and gene therapy analytics.

Application segmentation highlights the wide-ranging utility of amplification platforms. Agricultural testing leverages DNA-based assays to ensure crop quality and biosecurity. Drug discovery and development harness amplification assays for high-throughput screening and biomarker quantification. Environmental testing employs rapid isothermal methods for on-site pathogen detection. Medical diagnostics remains a critical growth engine, with genetic disorder screening, infectious disease panels, and oncology companion tests at the forefront. Finally, research fields such as epigenetics, genomics, and transcriptomics rely on tailored amplification strategies to decode complex biological pathways.

Key Regional Dynamics Shaping Growth Trajectories

The Americas continue to dominate in terms of R&D expenditure and early adoption of cutting-edge amplification technologies, underpinned by substantial funding for genomics initiatives, advanced diagnostic infrastructure, and a dense network of biotech clusters. North American laboratories are at the forefront of digital PCR integration, while South American research institutes are scaling isothermal platforms to address public health challenges.

In Europe, Middle East & Africa, regulatory harmonization and collaborative networks are accelerating cross-border trials and diagnostic rollouts. The region’s emphasis on personalized medicine is driving uptake of high-throughput qPCR systems and bioinformatics solutions. Meanwhile, Asia-Pacific is emerging as a powerhouse for low-cost isothermal devices and reagent manufacturing. Rapid market expansion in China, India, Japan, and Southeast Asia is fueled by government initiatives targeting infectious disease surveillance and agricultural biosecurity.

Competitive Landscape and Strategic Partnerships

Major players are intensifying efforts to expand product portfolios through both organic R&D and strategic acquisitions. Leading global corporations are investing heavily in microfluidic digital PCR platforms, while mid-sized firms are carving niches in point-of-care isothermal systems. Innovative startups are emerging with novel polymerases and proprietary amplification chemistries designed to enhance specificity and speed.

Collaborations between instrument manufacturers and software developers are enhancing user experiences, integrating cloud-based analytics with edge-computing devices to enable remote monitoring and real-time data sharing. Simultaneously, partnerships with academic centers are driving co-development of assays targeting rare genetic biomarkers and emerging pathogens. The competitive landscape is also witnessing the rise of reagent rental and subscription models as companies seek recurring revenue streams and deeper customer engagement.

Practical Strategies for Market Leadership

Industry leaders should prioritize investments in flexible manufacturing that can pivot between instrument assembly and reagent production to mitigate supply chain disruptions. Embracing modular design principles for amplification platforms will enable rapid customization for diverse applications, from clinical diagnostics to environmental monitoring. Companies must also deepen collaborations with software providers to deliver integrated end-to-end solutions that streamline data analysis and regulatory compliance.

Building robust local partnerships and establishing regional centers of excellence will be critical to navigating trade barriers and accelerating market access. Leaders should develop tiered service offerings, combining standard assay kits with on-demand custom services and expert training programs, to foster long-term customer loyalty. Finally, continuous engagement with regulatory bodies and standardization organizations will ensure alignment with evolving quality and safety requirements.

Rigorous Research Approach and Data Validation

This analysis synthesizes primary research conducted through interviews with senior executives at leading biotechnology firms, instrument manufacturers, and end-user organizations around the globe. Secondary data sources include peer-reviewed journals, patent filings, regulatory databases, and proprietary industry reports. Market segmentation was validated through triangulation of shipment data, pricing trends, and supplier financial disclosures.

Quantitative estimates were derived using bottom-up modeling of unit volumes across consumables, instruments, and software segments, while qualitative insights were extracted from expert perspectives on technology adoption, regulatory impacts, and competitive strategies. Regional market dynamics were assessed through an evaluation of public funding benchmarks, local manufacturing capacities, and policy frameworks influencing diagnostic and research investments.

Synthesis of Market Drivers and Strategic Imperatives

The gene amplification market stands at a critical inflection point, driven by technological breakthroughs, evolving regulatory landscapes, and dynamic end-user demands. Companies that harness the power of digital PCR, isothermal amplification, and advanced analytics will redefine standards for sensitivity, speed, and scalability.

As tariff pressures reshape supply chains and geopolitical factors influence market access, resilience and adaptability become key differentiators. By aligning R&D priorities with emerging applications and forging strategic partnerships across the value chain, stakeholders can capitalize on the expanding demand for precise nucleic acid detection and quantification. The insights contained in this report provide a roadmap for navigating complexity, optimizing investments, and capturing long-term growth opportunities.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Consumables & Reagents
      • Enzymes
      • Kits
      • Reagents
    • Instruments
      • Digital Pcr Instruments
      • Isothermal Instruments
      • Qpcr Instruments
      • Thermal Cyclers
    • Software & Services
      • Analysis Software
      • Custom Services
  • Technology Type
    • Digital Pcr
    • Isothermal Amplification
      • Hda
      • Lamp
      • Rpa
    • Pcr
    • Qpcr
  • End User
    • Academic Institutions
    • Diagnostic Laboratories
    • Hospitals & Clinics
    • Pharmaceutical Companies
      • Big Pharma
      • Biotech
    • Research Institutes
  • Application
    • Agricultural Testing
    • Drug Discovery & Development
    • Environmental Testing
    • Medical Diagnostics
      • Genetic Disorders
      • Infectious Disease
      • Oncology
    • Research
      • Epigenetics
      • Genomics
      • Transcriptomics
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Thermo Fisher Scientific Inc.
  • F. Hoffmann-La Roche Ltd.
  • QIAGEN N.V.
  • Danaher Corporation
  • Bio-Rad Laboratories, Inc.
  • Agilent Technologies, Inc.
  • Merck KGaA
  • Promega Corporation
  • Takara Bio Inc.
  • New England Biolabs, Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Gene Amplification Technologies Market, by Product Type
8.1. Introduction
8.2. Consumables & Reagents
8.2.1. Enzymes
8.2.2. Kits
8.2.3. Reagents
8.3. Instruments
8.3.1. Digital Pcr Instruments
8.3.2. Isothermal Instruments
8.3.3. Qpcr Instruments
8.3.4. Thermal Cyclers
8.4. Software & Services
8.4.1. Analysis Software
8.4.2. Custom Services
9. Gene Amplification Technologies Market, by Technology Type
9.1. Introduction
9.2. Digital Pcr
9.3. Isothermal Amplification
9.3.1. Hda
9.3.2. Lamp
9.3.3. Rpa
9.4. Pcr
9.5. Qpcr
10. Gene Amplification Technologies Market, by End User
10.1. Introduction
10.2. Academic Institutions
10.3. Diagnostic Laboratories
10.4. Hospitals & Clinics
10.5. Pharmaceutical Companies
10.5.1. Big Pharma
10.5.2. Biotech
10.6. Research Institutes
11. Gene Amplification Technologies Market, by Application
11.1. Introduction
11.2. Agricultural Testing
11.3. Drug Discovery & Development
11.4. Environmental Testing
11.5. Medical Diagnostics
11.5.1. Genetic Disorders
11.5.2. Infectious Disease
11.5.3. Oncology
11.6. Research
11.6.1. Epigenetics
11.6.2. Genomics
11.6.3. Transcriptomics
12. Americas Gene Amplification Technologies Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Gene Amplification Technologies Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Gene Amplification Technologies Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Thermo Fisher Scientific Inc.
15.3.2. F. Hoffmann-La Roche Ltd.
15.3.3. QIAGEN N.V.
15.3.4. Danaher Corporation
15.3.5. Bio-Rad Laboratories, Inc.
15.3.6. Agilent Technologies, Inc.
15.3.7. Merck KGaA
15.3.8. Promega Corporation
15.3.9. Takara Bio Inc.
15.3.10. New England Biolabs, Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. GENE AMPLIFICATION TECHNOLOGIES MARKET MULTI-CURRENCY
FIGURE 2. GENE AMPLIFICATION TECHNOLOGIES MARKET MULTI-LANGUAGE
FIGURE 3. GENE AMPLIFICATION TECHNOLOGIES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. GENE AMPLIFICATION TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. GENE AMPLIFICATION TECHNOLOGIES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. GENE AMPLIFICATION TECHNOLOGIES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY CONSUMABLES & REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY ENZYMES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY DIGITAL PCR INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY ISOTHERMAL INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY QPCR INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY THERMAL CYCLERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY ANALYSIS SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY CUSTOM SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY HDA, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY LAMP, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY RPA, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY QPCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY BIG PHARMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY BIOTECH, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY AGRICULTURAL TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY ENVIRONMENTAL TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY MEDICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY MEDICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY EPIGENETICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY GENOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TRANSCRIPTOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY MEDICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY MEDICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 78. CANADA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 79. CANADA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2030 (USD MILLION)
TABLE 80. CANADA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 81. CANADA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 82. CANADA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 83. CANADA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2030 (USD MILLION)
TABLE 84. CANADA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 85. CANADA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 86. CANADA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. CANADA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY MEDICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 88. CANADA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 89. MEXICO GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 90. MEXICO GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2030 (USD MILLION)
TABLE 91. MEXICO GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 92. MEXICO GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 93. MEXICO GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 94. MEXICO GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2030 (USD MILLION)
TABLE 95. MEXICO GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 96. MEXICO GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 97. MEXICO GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. MEXICO GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY MEDICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 99. MEXICO GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 100. BRAZIL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 101. BRAZIL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2030 (USD MILLION)
TABLE 102. BRAZIL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 103. BRAZIL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 104. BRAZIL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 108. BRAZIL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY MEDICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 111. ARGENTINA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 112. ARGENTINA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2030 (USD MILLION)
TABLE 113. ARGENTINA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 114. ARGENTINA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 115. ARGENTINA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 116. ARGENTINA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 118. ARGENTINA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 119. ARGENTINA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 120. ARGENTINA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY MEDICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 121. ARGENTINA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY MEDICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 134. UNITED KINGDOM GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 135. UNITED KINGDOM GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2030 (USD MILLION)
TABLE 136. UNITED KINGDOM GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 137. UNITED KINGDOM GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 138. UNITED KINGDOM GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 139. UNITED KINGDOM GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2030 (USD MILLION)
TABLE 140. UNITED KINGDOM GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY MEDICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 145. GERMANY GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 146. GERMANY GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2030 (USD MILLION)
TABLE 147. GERMANY GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 148. GERMANY GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 149. GERMANY GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 150. GERMANY GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2030 (USD MILLION)
TABLE 151. GERMANY GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 152. GERMANY GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 153. GERMANY GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 154. GERMANY GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY MEDICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 155. GERMANY GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 156. FRANCE GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 157. FRANCE GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2030 (USD MILLION)
TABLE 158. FRANCE GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 159. FRANCE GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 160. FRANCE GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 161. FRANCE GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2030 (USD MILLION)
TABLE 162. FRANCE GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 163. FRANCE GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 164. FRANCE GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 165. FRANCE GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY MEDICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 166. FRANCE GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 167. RUSSIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 168. RUSSIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2030 (USD MILLION)
TABLE 169. RUSSIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 170. RUSSIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 171. RUSSIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 172. RUSSIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2030 (USD MILLION)
TABLE 173. RUSSIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 174. RUSSIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 175. RUSSIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 176. RUSSIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY MEDICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 177. RUSSIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 178. ITALY GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 179. ITALY GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2030 (USD MILLION)
TABLE 180. ITALY GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 181. ITALY GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 182. ITALY GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 183. ITALY GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2030 (USD MILLION)
TABLE 184. ITALY GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 185. ITALY GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 186. ITALY GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 187. ITALY GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY MEDICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 188. ITALY GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 189. SPAIN GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 190. SPAIN GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2030 (USD MILLION)
TABLE 191. SPAIN GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 192. SPAIN GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 193. SPAIN GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 194. SPAIN GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2030 (USD MILLION)
TABLE 195. SPAIN GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 196. SPAIN GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 197. SPAIN GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 198. SPAIN GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY MEDICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 199. SPAIN GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 200. UNITED ARAB EMIRATES GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 201. UNITED ARAB EMIRATES GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2030 (USD MILLION)
TABLE 202. UNITED ARAB EMIRATES GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 203. UNITED ARAB EMIRATES GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 204. UNITED ARAB EMIRATES GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 205. UNITED ARAB EMIRATES GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2030 (USD MILLION)
TABLE 206. UNITED ARAB EMIRATES GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 207. UNITED ARAB EMIRATES GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 208. UNITED ARAB EMIRATES GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 209. UNITED ARAB EMIRATES GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY MEDICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 210. UNITED ARAB EMIRATES GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 211. SAUDI ARABIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 212. SAUDI ARABIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2030 (USD MILLION)
TABLE 213. SAUDI ARABIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 214. SAUDI ARABIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 215. SAUDI ARABIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 216. SAUDI ARABIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2030 (USD MILLION)
TABLE 217. SAUDI ARABIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 218. SAUDI ARABIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 219. SAUDI ARABIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 220. SAUDI ARABIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY MEDICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 221. SAUDI ARABIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 222. SOUTH AFRICA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 223. SOUTH AFRICA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2030 (USD MILLION)
TABLE 224. SOUTH AFRICA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 225. SOUTH AFRICA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 226. SOUTH AFRICA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 227. SOUTH AFRICA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2030 (USD MILLION)
TABLE 228. SOUTH AFRICA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 229. SOUTH AFRICA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 230. SOUTH AFRICA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 231. SOUTH AFRICA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY MEDICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 232. SOUTH AFRICA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 233. DENMARK GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 234. DENMARK GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2030 (USD MILLION)
TABLE 235. DENMARK GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 236. DENMARK GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 237. DENMARK GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 238. DENMARK GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2030 (USD MILLION)
TABLE 239. DENMARK GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 240. DENMARK GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 241. DENMARK GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 242. DENMARK GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY MEDICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 243. DENMARK GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 244. NETHERLANDS GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 245. NETHERLANDS GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2030 (USD MILLION)
TABLE 246. NETHERLANDS GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 247. NETHERLANDS GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 248. NETHERLANDS GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 249. NETHERLANDS GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2030 (USD MILLION)
TABLE 250. NETHERLANDS GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 251. NETHERLANDS GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 252. NETHERLANDS GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 253. NETHERLANDS GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY MEDICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 254. NETHERLANDS GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 255. QATAR GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 256. QATAR GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2030 (USD MILLION)
TABLE 257. QATAR GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 258. QATAR GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 259. QATAR GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 260. QATAR GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2030 (USD MILLION)
TABLE 261. QATAR GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 262. QATAR GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 263. QATAR GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 264. QATAR GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY MEDICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 265. QATAR GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 266. FINLAND GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 267. FINLAND GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2030 (USD MILLION)
TABLE 268. FINLAND GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 269. FINLAND GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 270. FINLAND GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 271. FINLAND GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2030 (USD MILLION)
TABLE 272. FINLAND GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 273. FINLAND GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 274. FINLAND GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 275. FINLAND GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY MEDICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 276. FINLAND GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 277. SWEDEN GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 278. SWEDEN GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2030 (USD MILLION)
TABLE 279. SWEDEN GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 280. SWEDEN GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 281. SWEDEN GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 282. SWEDEN GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2030 (USD MILLION)
TABLE 283. SWEDEN GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 284. SWEDEN GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 285. SWEDEN GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 286. SWEDEN GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY MEDICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 287. SWEDEN GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 288. NIGERIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 289. NIGERIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2030 (USD MILLION)
TABLE 290. NIGERIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 291. NIGERIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 292. NIGERIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 293. NIGERIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2030 (USD MILLION)
TABLE 294. NIGERIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 295. NIGERIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 296. NIGERIA GENE AMPLIFICATION TECH

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Gene Amplification Technologies market report include:
  • Thermo Fisher Scientific Inc.
  • F. Hoffmann-La Roche Ltd.
  • QIAGEN N.V.
  • Danaher Corporation
  • Bio-Rad Laboratories, Inc.
  • Agilent Technologies, Inc.
  • Merck KGaA
  • Promega Corporation
  • Takara Bio Inc.
  • New England Biolabs, Inc.

Table Information

Report AttributeDetails
No. of Pages191
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 29.16 Billion
Forecasted Market Value ( USD ) by 2030 $ 36.22 Billion
Compound Annual Growth Rate4.4%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Gene Amplification Technologies - Global Strategic Business Report - Product Image

Gene Amplification Technologies - Global Strategic Business Report

  • Report
  • 293 Pages
  • Global
From
NGS-Based RNA-Sequencing Market by Application, Product, End User, Workflow, Technology - Global Forecast to 2030 - Product Image

NGS-Based RNA-Sequencing Market by Application, Product, End User, Workflow, Technology - Global Forecast to 2030

  • Report
  • 185 Pages
  • Global
From
Whole Genome Bisulfite Sequencing Market Size, Share & Trends Analysis Report by Product & Service (Kits & Reagents), Workflow, Application (Drug Development, Stem Cell Research), End-Use, and Region with Growth Forecasts, 2025-2030 - Product Image

Whole Genome Bisulfite Sequencing Market Size, Share & Trends Analysis Report by Product & Service (Kits & Reagents), Workflow, Application (Drug Development, Stem Cell Research), End-Use, and Region with Growth Forecasts, 2025-2030

  • Report
  • 100 Pages
  • Global
From
U.S. Epigenetics Market Size, Share & Trends Analysis Report by Product (Reagents, Kits), Technology (DNA Methylation, Histone Methylation), Application (Oncology, Non-oncology), End-use, and Segment Forecasts, 2024-2030 - Product Image

U.S. Epigenetics Market Size, Share & Trends Analysis Report by Product (Reagents, Kits), Technology (DNA Methylation, Histone Methylation), Application (Oncology, Non-oncology), End-use, and Segment Forecasts, 2024-2030

  • Report
  • 90 Pages
  • United States
From
Custom Plasmid Production & Manufacturing Market by Service Type, Application, End User, Plasmid Type, Scale - Global Forecast to 2030 - Product Image

Custom Plasmid Production & Manufacturing Market by Service Type, Application, End User, Plasmid Type, Scale - Global Forecast to 2030

  • Report
  • 183 Pages
  • Global
From

About the Gene Amplification Market

Gene Amplification is a process used in genomics to increase the amount of a specific gene or gene sequence in a sample. It is used to study gene expression, to detect genetic mutations, and to produce large amounts of a gene for further study. The process involves the use of enzymes to replicate a gene or gene sequence multiple times, resulting in an amplified sample. The Gene Amplification market is an important part of the genomics industry, as it provides the tools and techniques necessary to study gene expression and detect genetic mutations. It is also used in the production of gene-based therapeutics, diagnostics, and research tools. Companies in the Gene Amplification market include Thermo Fisher Scientific, Illumina, Agilent Technologies, QIAGEN, Bio-Rad Laboratories, and Merck KGaA. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.